4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001883986-25-000009
Chief Legal Officer sold 33,807 shares at $14.75 ($498,653)
- Chief Legal Officer acquired 33,807 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2025-09-29 | Option exercise 10b5-1 | +33,807 | $9.24 | $312,495 | 33,807 | D |
| Meisner Lara Chief Legal Officer | 2025-09-29 | Sale 10b5-1 | −33,807 | $14.75 | $498,653 | 0 | D |
| Derivatives | |||||||
| Meisner Lara Chief Legal Officer | 2025-09-29 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −33,807 | 101,423 | D | ||
| Open-market sales · 33,807 sh · avg $14.75 · $498,653 | |||||||
Loading xslF345X05/wk-form4_1759352250.xml…